Ideaya Biosciences Inc. (IDYA)
NASDAQ · Healthcare
Ideaya Biosciences Inc. EBITDA 2019–2025
Ideaya Biosciences Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Ideaya Biosciences Inc. ebitda for the quarter ending March 31, 2026 was -107.9 M, a 114.00% increase year-over-year.
- Ideaya Biosciences Inc. ebitda for the twelve months ending March 31, 2026 was -129.3 M, a 8.36% decrease year-over-year.
- Ideaya Biosciences Inc. annual ebitda for 2025 was -156.6 M, a 51.75% decrease from 2024.
- Ideaya Biosciences Inc. annual ebitda for 2024 was -324.6 M, a 145.99% increase from 2023.
- Ideaya Biosciences Inc. annual ebitda for 2023 was -132.0 M, a 118.46% increase from 2022.
- Ideaya Biosciences Inc. annual ebitda for 2022 was -60.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ideaya Biosciences Inc. EBITDA — FAQ
Ideaya Biosciences Inc. (IDYA) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IDYA's ebitda history?
The chart and table above show Ideaya Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.